Reuters logo
3 个月前
BRIEF-Inotek Pharmaceuticals Corp posts Q1 loss per share $0.40
2017年5月10日 / 上午11点15分 / 3 个月前

BRIEF-Inotek Pharmaceuticals Corp posts Q1 loss per share $0.40

May 10 (Reuters) - Inotek Pharmaceuticals Corp

* Inotek Pharmaceuticals Corporation reports first quarter 2017 financial results and operational highlights

* Inotek Pharmaceuticals Corp qtrly loss per share $0.40

* Inotek Pharmaceuticals Corp qtrly research and development expenses were $7.1 million, compared to $7.6 million for quarter ended March 31, 2016

* Inotek Pharmaceuticals - communicated with U.S. FDA regarding matrx-1 results, FDA in agreement that trial did not meet its primary efficacy endpoint

* Inotek Pharmaceuticals - is evaluating potential for selective adenosine mimetics to address optic neuropathies and other degenerative retinal diseases Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below